Status:
COMPLETED
Pilot Randomized-controlled Trial of Integrated Palliative and Nephrology Care Versus Usual Nephrology Care.
Lead Sponsor:
NYU Langone Health
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The objective of this application is to conduct a pilot study testing the impact of integrated nephrology and palliative care versus standard nephrology care on patient-reported outcomes. This study i...
Eligibility Criteria
Inclusion
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Age ≥18
- Fluent English speaker
- eGFR≤15 mL/min/1.73m2 (diagnosis of CKD stage V)
- Able to give consent
- Must be followed by a faculty group practice nephrologist
Exclusion
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Diagnosis of dementia
- Non-English speaker
- Have been seen by a palliative care provider prior to study entry
- Pregnant women
- On dialysis or have received a kidney transplant
Key Trial Info
Start Date :
July 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 26 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04520984
Start Date
July 12 2020
End Date
April 26 2021
Last Update
October 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016